ICU Medical, Inc. (ICUI)

NASDAQ: ICUI · IEX Real-Time Price · USD
86.25
-1.24 (-1.42%)
At close: Dec 8, 2023, 4:00 PM
86.15
-0.10 (-0.12%)
After-hours: Dec 8, 2023, 4:55 PM EST

Cash Flow Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013 2012 - 1994
Net Income
-74.29103.1486.87101.0428.7968.6463.0844.9926.3440.42
Upgrade
Depreciation & Amortization
258.899.2994.8585.2174.7466.5719.0518.0719.4519.51
Upgrade
Share-Based Compensation
36.0327.3423.9521.9224.2419.3515.2412.839.595.43
Upgrade
Other Operating Activities
-282.6737.7717.08-106.2532.45-0.14-7.44-11.6910.970.37
Upgrade
Operating Cash Flow
-62.13267.54222.75101.92160.22154.4289.9464.266.3465.73
Upgrade
Operating Cash Flow Growth
-20.11%118.56%-36.39%3.75%71.69%40.11%-3.23%0.93%-0.82%
Upgrade
Capital Expenditures
-98.34-80.95-94.21-106.01-100.01-79.68-24.55-10.34-17.59-19.45
Upgrade
Acquisitions
-1,844.16-14.450-76.13-1.3-162.45-2.58-27.8200
Upgrade
Change in Investments
33.044.72-3.9315.25-15.06-24.7440.1526.92-4.166.33
Upgrade
Other Investing Activities
----13-3.27---
Upgrade
Investing Cash Flow
-1,909.47-90.69-98.14-166.89-103.37-266.8716.28-11.24-21.75-13.12
Upgrade
Share Issuance / Repurchase
8.799.3713.197.7314.2830.652.4715.6813.6517.43
Upgrade
Debt Issued / Paid
1,639-0.61-0.3600-750000
Upgrade
Other Financing Activities
-10.88-25.64-12.88-18.64-6.25----6.97
Upgrade
Financing Cash Flow
1,637-16.87-0.04-10.918.02-44.352.4715.6813.6524.39
Upgrade
Exchange Rate Effect
-9.48-3.252.85-0.23-10.161.790.22-8.28-8.452.12
Upgrade
Net Cash Flow
-344.04156.73127.43-76.1154.71-155.01108.9260.3549.7979.12
Upgrade
Free Cash Flow
-160.47186.59128.54-4.0960.274.7465.3953.8548.7546.28
Upgrade
Free Cash Flow Growth
-45.16%---19.46%14.31%21.42%10.46%5.34%0.66%
Upgrade
Free Cash Flow Margin
-7.04%14.18%10.11%-0.32%4.30%5.78%17.24%15.76%15.76%14.75%
Upgrade
Free Cash Flow Per Share
-6.728.806.15-0.202.953.814.043.403.193.15
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).